Resources

Publications

11/03/2023
- Oncology
A multi-modal, pan-cancer atlas of tumor-immune states across primary and metastatic disease using a large, real-world database
SITC 2023
11/03/2023
- Oncology
Associations between multimodal immune biomarkers and clinical outcomes in a real-world non-small cell lung cancer cohort
SITC 2023
11/03/2023
- Oncology
Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
SITC 2023
11/02/2023
- Oncology
PPARG Amplification Is Associated With Lack of Response to Anti-PD1 in Muscle-Invasive Urothelial Cancer
SITC 2023
11/01/2023
- Oncology
RNA Sequencing to Characterize Pathways in Patients with EGFR-mutated Non-Small Cell Lung Cancer
IASLC WCLC 2023
10/16/2023
- Oncology
Genomic characterization of sporadic MET amplified non-small cell lung cancer (NSCLC) and association with real-world outcomes
ESMO 2023
10/16/2023
- Oncology
Real-world data analysis of genomic profiling-matched targeted therapy outcomes in patients with fusion-positive NSCLC
ESMO 2023
10/16/2023
- Oncology
Avelumab first-line maintenance (1LM) for locally advanced or metastatic urothelial carcinoma (la/mUC): Treatment (tx) patterns and real-world (rw) outcomes in the US
ESMO 2023
10/16/2023
- Oncology
Comparative analysis of the tumor immune microenvironment (TIME) in primary and metastatic sites of microsatellite stable (MSS) and microsatellite instability-high (MSI) colorectal cancer
ESMO 2023
10/16/2023
- Oncology
ALK fusion detection by RNA next-generation sequencing (NGS) compared to DNA in a large, real-world non-small cell lung cancer (NSCLC) dataset
ESMO 2023

27 28 29